Hege M. Krabseth

Author information from the last article

Hege M. Krabseth (f.1977) er lege i spesialisering i klinisk farmakologi. Hun har, sammen med de andre forfatterne, bidratt med datainnsamling, skriving, litteratursøk og revisjon av manus.

Forfatter har fylt ut ICMJE-skjemaet og oppgir ingen interessekonflikter.

Avdeling for farmakologi

Oslo universitetssykehus

Articles by Hege M. Krabseth

Novel psychoactive substances

Hege M. Krabseth,
Silja S. Tuv,
Maren Cecilie Strand,
Ritva A. Karinen,
Elisabeth Wiik,
Merete S. Vevelstad,
Andreas Austgulen Westin,
Elisabeth L. Øiestad,
Vigdis Vindenes

03.05.2016: There has been a major increase in the number of new drugs of abuse on the global illicit drugs market, including in Norway. These substances are referred to as «novel psychoactive substances» (NPS), and are mainly sold over the Internet. Potent substances in uncertain doses entail a risk of...

New designer drugs from the web

Silja S. Tuv,
Hege M. Krabseth,
Maren Cecilie Strand,
Ritva A. Karinen,
Elisabeth Wiik,
Merete S. Vevelstad,
Andreas Austgulen Westin,
Elisabeth L. Øiestad,
Vigdis Vindenes

03.05.2016: The illicit drugs market has changed in recent years, and the Internet has become increasingly important as a distribution channel. During the first six months of 2015, more than 200 000 user doses of novel psychoactive substances (NPS) were impounded in Norway. Many of these substances are toxic...